156 related articles for article (PubMed ID: 34103473)
1. Human umbilical cord mesenchymal stem cell transfusion in immune non-responders with AIDS: a multicenter randomized controlled trial.
Wang L; Zhang Z; Xu R; Wang X; Shu Z; Chen X; Wang S; Liu J; Li Y; Wang L; Zhang M; Yang W; Wang Y; Huang H; Tu B; Liang Z; Li L; Li J; Hou Y; Shi M; Wang FS
Signal Transduct Target Ther; 2021 Jun; 6(1):217. PubMed ID: 34103473
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of human umbilical cord-derived mesenchymal stem cells (hUC-MSC PLEB001) for the treatment of grade II-IV steroid-refractory acute graft-versus-host disease: a study protocol for a multicenter, randomized, double-blind, placebo-controlled, phase II trial.
Yang D; Hou X; Qian K; Li Y; Hu L; Li L; Han M; Yao C; Liu D
Trials; 2023 May; 24(1):306. PubMed ID: 37138332
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of umbilical cord tissue-derived mesenchymal stem cells in the treatment of patients with aging frailty: a phase I/II randomized, double-blind, placebo-controlled study.
Zhu Y; Huang C; Zheng L; Li Q; Ge J; Geng S; Zhai M; Chen X; Yuan H; Li Y; Jia W; Sun K; Li Y; Ye T; Zhao Z; Liu H; Liu Z; Jiang H
Stem Cell Res Ther; 2024 Apr; 15(1):122. PubMed ID: 38679727
[TBL] [Abstract][Full Text] [Related]
4. Extracellular Vesicles Released from Human Umbilical Cord-Derived Mesenchymal Stromal Cells Prevent Life-Threatening Acute Graft-Versus-Host Disease in a Mouse Model of Allogeneic Hematopoietic Stem Cell Transplantation.
Wang L; Gu Z; Zhao X; Yang N; Wang F; Deng A; Zhao S; Luo L; Wei H; Guan L; Gao Z; Li Y; Wang L; Liu D; Gao C
Stem Cells Dev; 2016 Dec; 25(24):1874-1883. PubMed ID: 27649744
[TBL] [Abstract][Full Text] [Related]
5. Safety and immunological responses to human mesenchymal stem cell therapy in difficult-to-treat HIV-1-infected patients.
Zhang Z; Fu J; Xu X; Wang S; Xu R; Zhao M; Nie W; Wang X; Zhang J; Li T; Su L; Wang FS
AIDS; 2013 May; 27(8):1283-93. PubMed ID: 23925377
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic evidence of umbilical cord-derived mesenchymal stem cell transplantation for cerebral palsy: a randomized, controlled trial.
Gu J; Huang L; Zhang C; Wang Y; Zhang R; Tu Z; Wang H; Zhou X; Xiao Z; Liu Z; Hu X; Ke Z; Wang D; Liu L
Stem Cell Res Ther; 2020 Feb; 11(1):43. PubMed ID: 32014055
[TBL] [Abstract][Full Text] [Related]
7. Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients With Heart Failure: A Phase 1/2 Randomized Controlled Trial (RIMECARD Trial [Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy]).
Bartolucci J; Verdugo FJ; González PL; Larrea RE; Abarzua E; Goset C; Rojo P; Palma I; Lamich R; Pedreros PA; Valdivia G; Lopez VM; Nazzal C; Alcayaga-Miranda F; Cuenca J; Brobeck MJ; Patel AN; Figueroa FE; Khoury M
Circ Res; 2017 Oct; 121(10):1192-1204. PubMed ID: 28974553
[TBL] [Abstract][Full Text] [Related]
8. Human Umbilical Cord Mesenchymal Stem Cells to Treat Neuromyelitis Optica Spectrum Disorder (hUC-MSC-NMOSD): A Study Protocol for a Prospective, Multicenter, Randomized, Placebo-Controlled Clinical Trial.
Yao XY; Xie L; Cai Y; Zhang Y; Deng Y; Gao MC; Wang YS; Xu HM; Ding J; Wu YF; Zhao N; Wang Z; Song YY; Wang LP; Xie C; Li ZZ; Wan WB; Lin Y; Jin HF; Wang K; Qiu HY; Zhuang L; Zhou Y; Jin YY; Ni LP; Yan JL; Guo Q; Xue JH; Qian BY; Guan YT
Front Neurol; 2022; 13():860083. PubMed ID: 35547390
[TBL] [Abstract][Full Text] [Related]
9. Safety evaluation of human umbilical cord-mesenchymal stem cells in type 2 diabetes mellitus treatment: A phase 2 clinical trial.
Lian XF; Lu DH; Liu HL; Liu YJ; Yang Y; Lin Y; Xie F; Huang CH; Wu HM; Long AM; Hui CJ; Shi Y; Chen Y; Gao YF; Zhang F
World J Clin Cases; 2023 Jul; 11(21):5083-5096. PubMed ID: 37583846
[TBL] [Abstract][Full Text] [Related]
10. Human Umbilical Cord Mesenchymal Stromal Cell Treatment of Severe COVID-19 Patients: A 3-Month Follow-Up Study Following Hospital Discharge.
Feng G; Shi L; Huang T; Ji N; Zheng Y; Lin H; Niu C; Wang Y; Li R; Huang M; Chen X; Shu L; Wu M; Deng K; Wei J; Wang X; Cao Y; Yan J
Stem Cells Dev; 2021 Aug; 30(15):773-781. PubMed ID: 34044609
[TBL] [Abstract][Full Text] [Related]
11. Allogeneic human umbilical cord-derived mesenchymal stem cells for severe bronchopulmonary dysplasia in children: study protocol for a randomized controlled trial (MSC-BPD trial).
Wu X; Xia Y; Zhou O; Song Y; Zhang X; Tian D; Li Q; Shu C; Liu E; Yuan X; He L; Liu C; Li J; Liang X; Yang K; Fu Z; Zou L; Bao L; Dai J
Trials; 2020 Jan; 21(1):125. PubMed ID: 32005282
[TBL] [Abstract][Full Text] [Related]
12. Repeated subarachnoid administrations of allogeneic human umbilical cord mesenchymal stem cells for spinal cord injury: a phase 1/2 pilot study.
Yang Y; Pang M; Du C; Liu ZY; Chen ZH; Wang NX; Zhang LM; Chen YY; Mo J; Dong JW; Xie PG; Wang QY; Liu B; Rong LM
Cytotherapy; 2021 Jan; 23(1):57-64. PubMed ID: 33218835
[TBL] [Abstract][Full Text] [Related]
13. Subarachnoid transplantation of human umbilical cord mesenchymal stem cell in rodent model with subacute incomplete spinal cord injury: Preclinical safety and efficacy study.
Yang Y; Cao TT; Tian ZM; Gao H; Wen HQ; Pang M; He WJ; Wang NX; Chen YY; Wang Y; Li H; Lin JW; Kang Z; Li MM; Liu B; Rong LM
Exp Cell Res; 2020 Oct; 395(2):112184. PubMed ID: 32707134
[TBL] [Abstract][Full Text] [Related]
14. Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells.
Shu L; Niu C; Li R; Huang T; Wang Y; Huang M; Ji N; Zheng Y; Chen X; Shi L; Wu M; Deng K; Wei J; Wang X; Cao Y; Yan J; Feng G
Stem Cell Res Ther; 2020 Aug; 11(1):361. PubMed ID: 32811531
[TBL] [Abstract][Full Text] [Related]
15. A randomised double-blind, placebo-controlled trial of allogeneic umbilical cord-derived mesenchymal stem cell for lupus nephritis.
Deng D; Zhang P; Guo Y; Lim TO
Ann Rheum Dis; 2017 Aug; 76(8):1436-1439. PubMed ID: 28478399
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic mesenchymal stem cells as induction therapy are safe and feasible in renal allografts: pilot results of a multicenter randomized controlled trial.
Sun Q; Huang Z; Han F; Zhao M; Cao R; Zhao D; Hong L; Na N; Li H; Miao B; Hu J; Meng F; Peng Y; Sun Q
J Transl Med; 2018 Mar; 16(1):52. PubMed ID: 29514693
[TBL] [Abstract][Full Text] [Related]
17. Human Umbilical Cord Mesenchymal Stromal Cell Transplantation in Myocardial Ischemia (HUC-HEART Trial). A Study Protocol of a Phase 1/2, Controlled and Randomized Trial in Combination with Coronary Artery Bypass Grafting.
Can A; Ulus AT; Cinar O; Topal Celikkan F; Simsek E; Akyol M; Canpolat U; Erturk M; Kara F; Ilhan O
Stem Cell Rev Rep; 2015 Oct; 11(5):752-60. PubMed ID: 26123356
[TBL] [Abstract][Full Text] [Related]
18. Chronic Toxicity Test in Cynomolgus Monkeys For 98 Days with Repeated Intravenous Infusion of Cynomolgus Umbilical Cord Mesenchymal Stem Cells.
He J; Ruan GP; Yao X; Liu JF; Zhu XQ; Zhao J; Pang RQ; Li ZA; Pan XH
Cell Physiol Biochem; 2017; 43(3):891-904. PubMed ID: 28957810
[TBL] [Abstract][Full Text] [Related]
19. Phase II Multicenter, Randomized, Double-Blind Controlled Study of Efficacy and Safety of Umbilical Cord-Derived Mesenchymal Stromal Cells in the Prophylaxis of Chronic Graft-Versus-Host Disease After HLA-Haploidentical Stem-Cell Transplantation.
Gao L; Zhang Y; Hu B; Liu J; Kong P; Lou S; Su Y; Yang T; Li H; Liu Y; Zhang C; Gao L; Zhu L; Wen Q; Wang P; Chen X; Zhong J; Zhang X
J Clin Oncol; 2016 Aug; 34(24):2843-50. PubMed ID: 27400949
[TBL] [Abstract][Full Text] [Related]
20. Effects of single and multiple transplantations of human umbilical cord mesenchymal stem cells on the recovery of ovarian function in the treatment of premature ovarian failure in mice.
Lv X; Guan C; Li Y; Su X; Zhang L; Wang X; Xia HF; Ma X
J Ovarian Res; 2021 Sep; 14(1):119. PubMed ID: 34526090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
